Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence
SIR -The endogenous cannabinoid system is thought to be an important neuromodulator in motivation, reward and motor control systems. 1 Observations using animal models suggest that modulation of endogenous central cannabinoid signaling in mesolimbic pathways may be one component of the addiction process, particularly via interaction with opioid and dopaminergic systems. [2] [3] [4] Loss of central cannabinoid signaling in CB1 knockout mice reduces the addictive properties of opiates. 5 Based on a case-control study of the cannabinoid receptor gene (CNR1, 6q14-15), in which they observed an increased frequency of long (AAT) n repeats in a group of drug-dependent non-Hispanic Caucasians from Southern California, Comings et al 6 hypothesized that changes in the level of expression of the central cannabinoid receptor (CB1) may contribute to drug but not alcohol dependence. We report here an attempt to replicate those findings in a case-control study of 399 European-American (EA) and 130 AfricanAmerican (AA) subjects recruited in southern New England. No significant differences in the frequencies of CNR1 (AAT) n repeats were observed in either population for drug-or alcohol-dependent subjects compared with controls. Significant differences in allele frequencies were observed between EA and AA control groups.
PCR amplification of the (AAT) n repeat 7 was carried out using 50 ng of DNA with primers 32P-GCTGCTTCTGTTAACCCTGC and TACATCTCCGTGT GATGTTCC, 1.5 mM MgCl 2 , and 48°C as annealing temperature. Nine allele types were identified from autoradiographs of polyacrylamide gels. Allele numbering is as described by Comings et al. 6 Chi-square statistical testing for comparison of allele distributions was carried out using the CLUMP program. 8 Substance 
10
Molecular Psychiatry use disorders were confirmed using the Structured Clinical Interview 9 for DSM-III-R or for DSM-IV. Written informed consent was obtained from all subjects prior to diagnostic interview and phlebotomy.
The distribution of CNR1 alleles is shown in Table  1 . In contrast to the report by Comings et al 6 of an increased frequency of long repeats (alleles 5-9) for drug-dependent subjects, we observed no significant differences in allele distributions when drug-dependent EA subjects were compared with EA controls ( 2 = 5.0, 7 df, P = 0.29). In the earlier study by Comings et al, 6 the greatest divergence in allele frequency was for subjects using drugs by high intensity routes (intravenous and smoking). When the subset of subjects using crack and/or intravenous opiates was examined separately, we again failed to detect significant differences in the CNR1 allele distribution compared with EA controls ( 2 = 6.1, 7 df, P = 0.19). In agreement with Comings et al, 6 we observed no significant difference in allele distribution between EA control and EA alcohol-dependent subjects ( 2 = 5.1, 7 df, P = 0.29). The allele distribution observed for AA control subjects was significantly different from that for EA controls ( 2 = 54.4, 7 df, P Ͻ 0.0001). AA subjects had a higher frequency of allele 5 and reduced frequencies for alleles 7 and 8. No statistically significant difference in the distribution of CNR1 alleles for AA drug-dependent subjects was observed ( 2 = 4.7, 7 df, P = 0.45), even when the analysis included only those subjects using crack and/or intravenous opiates ( 2 = 4.8, 7 df, P = 0.45). The size of our EA sample was sufficient to provide 90% power to detect a difference at the 0.05 significance level for a change in allele distribution of the magnitude reported by Comings et al 6 for crack/IV drug-dependent subjects. The smaller size of our AA control sample limited power to 70% for this population.
Our results are similar to those of Li et al 10 who, using a large sample of Han Chinese, found no evidence that alleles in the (ATT) n CNR1 microsatellite system are associated with heroin dependence. These authors noted that the allele distribution for Chinese subjects was quite different from that reported for Caucasians by Comings et al. 6 The allele distribution reported for Chinese controls 10 is shown in Table 1 for comparison with our results. In Chinese controls, allele types 6 and 7 are most abundant, representing 40% and 22% of alleles, respectively. Alleles 4 and 8, which are the most common for our EA controls, had frequencies of only 5% and 3%, respectively, in Chinese controls. Comparison of allele distributions for EA, AA and Chinese subjects demonstrates that the CNR1 (AAT) n microsatellite system shows marked variation by population and suggests that case-control studies using this marker may be subject to significant Type I error from population stratification. Other genetic markers associated with CNR1 and/or subject samples not influenced by population stratification (eg, family-based samples) will be needed to test the hypothesis that the CNR1 gene is associated with substance dependence.
